Elena N Levtchenko Selected Research

Fanconi Syndrome (Syndrome, Fanconi)

1/2016	Altered mTOR signalling in nephropathic cystinosis.
1/2016	Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
1/2015	Endo-lysosomal dysfunction in human proximal tubular epithelial cells deficient for lysosomal cystine transporter cystinosin.
9/2013	Copper deficiency in patients with cystinosis with cysteamine toxicity.
6/2011	Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells.
11/2008	Mitochondrial complex V expression and activity in cystinotic fibroblasts.
6/2008	Urinary protein excretion pattern and renal expression of megalin and cubilin in nephropathic cystinosis.
11/2005	Elevated oxidized glutathione in cystinotic proximal tubular epithelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena N Levtchenko Research Topics

Disease

28	Cystinosis 01/2021 - 10/2002
8	Fanconi Syndrome (Syndrome, Fanconi) 01/2016 - 11/2005
5	Renal Insufficiency (Renal Failure) 01/2018 - 10/2002
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2016 - 10/2002
3	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 10/2009 - 05/2007
2	Albuminuria 01/2022 - 07/2019
2	Inborn Genetic Diseases (Disease, Hereditary) 09/2018 - 02/2017
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2018 - 01/2016
2	Disease Progression 01/2015 - 05/2007
2	Proteinuria 04/2013 - 06/2008
2	Chronic Renal Insufficiency 11/2012 - 06/2011
2	Alkalosis 06/2011 - 07/2008
2	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2008 - 05/2007
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Kidney Diseases (Kidney Disease) 07/2019
1	Infections 07/2019
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2018
1	Cysts 01/2018
1	Halitosis 02/2017
1	Starvation 01/2016
1	Hypogonadism (Hypergonadotropic Hypogonadism) 08/2015
1	Hypothyroidism 08/2015
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 08/2015
1	Thrombosis (Thrombus) 08/2015
1	Splenomegaly 08/2015
1	Pancytopenia 08/2015
1	Hyperplasia 08/2015
1	Portal Hypertension 08/2015
1	Sotos Syndrome 07/2014
1	Infantile Hypercalcemia 07/2014
1	Hypercalcemia (Milk Alkali Syndrome) 07/2014
1	Dent Disease 04/2013
1	Hypercalciuria 04/2013
1	Nephrolithiasis 04/2013
1	Stroke (Strokes) 06/2011
1	Hypokalemia 06/2011
1	Atherosclerotic Plaque (Atheroma) 06/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2011
1	Anorexia 06/2011
1	Hypertension (High Blood Pressure) 06/2011
1	Failure to Thrive 06/2011
1	Atherosclerosis 06/2011
1	Seizures (Absence Seizure) 09/2010
1	Azoospermia 04/2010
1	Herpes Zoster 02/2010
1	Gitelman Syndrome 07/2008
1	Prolactinoma (Prolactinomas) 02/2008

Drug/Important Bio-Agent (IBA)

22	Cystine (L-Cystine)IBA 01/2018 - 10/2002
13	Cysteamine (Mercaptamine)FDA Link 02/2017 - 10/2002
4	Proteins (Proteins, Gene)FDA Link 01/2015 - 06/2008
4	Adenosine Triphosphate (ATP)IBA 06/2011 - 02/2006
3	CreatinineIBA 01/2022 - 04/2008
3	AlbuminsIBA 07/2019 - 06/2008
3	Growth Hormone (Somatotropin)IBA 11/2012 - 07/2004
2	histidine-rich proteinsIBA 01/2021 - 07/2019
2	CalciumIBA 01/2018 - 07/2008
2	CarbohydratesIBA 02/2017 - 04/2008
2	Low Density Lipoprotein Receptor-Related Protein-2IBA 04/2013 - 06/2008
2	intrinsic factor-cobalamin receptorIBA 04/2013 - 06/2008
2	SteroidsIBA 10/2009 - 05/2007
1	Biological ProductsIBA 01/2021
1	Apolipoprotein L1IBA 01/2021
1	ProdrugsIBA 02/2017
1	ThiazolidinesIBA 02/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2016
1	Amino Acids FDA Link 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 07/2014
1	MineralsIBA 07/2014
1	Type 4 Fibroblast Growth Factor ReceptorIBA 07/2014
1	Copper Transport ProteinsIBA 09/2013
1	Procollagen Type IIBA 09/2013
1	CopperIBA 09/2013
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 09/2013
1	AntiportersIBA 04/2013
1	Protons (Proton)IBA 04/2013
1	ChloridesIBA 04/2013
1	Human Growth Hormone (Saizen)FDA LinkGeneric 11/2012
1	methylamphotericin B (AME)IBA 06/2011
1	ElectrolytesIBA 06/2011
1	Mineralocorticoid Receptor AntagonistsIBA 06/2011
1	Glutathione (Reduced Glutathione)IBA 06/2011
1	Vasopressins (Vasopressin)IBA 09/2010
1	Aquaporin 1IBA 02/2010
1	Alkaline PhosphataseIBA 02/2010
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 02/2010
1	CD13 Antigens (Alanine Aminopeptidase)IBA 02/2010
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2008
1	Immunoglobulin G (IgG)IBA 06/2008
1	ErythritolIBA 04/2008
1	EnzymesIBA 04/2008
1	sedoheptuloseIBA 04/2008
1	Phosphotransferases (Kinase)IBA 04/2008
1	Dopamine Agonists (Dopamine Agonist)IBA 02/2008

Therapy/Procedure

5	Therapeutics 06/2016 - 07/2004
1	Precision Medicine 09/2018
1	Transplantation 06/2016
1	Kidney Transplantation 09/2013
1	Renal Dialysis (Hemodialysis) 09/2013